undamentalytics Newsletter
Sign in

10x Genomics, Inc. balance sheet

At the end of fiscal 2025, 10x Genomics, Inc. had total assets of $1.04bn, total liabilities of $245m and shareholders' equity of $796m. It held $474m in cash against $0 of debt: net cash of $474m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents4865424664587220359344474503
Receivables—28335185104115884748
Inventory—91530608274835653
Total current assets—106481774748635596584684675
Goodwill———0555557
Total assets—124469291,0191,0299659191,0411,030
Accounts payable—9135172216131321
Deferred revenue (current)—2345813212424
Total current liabilities—3263118110131127118153119
Short-term debt—4100——————
Long-term debt—25200——————
Total debt030300000000
Total liabilities—10178190201223224209245205
Shareholders' equity−113−220420739818806741710796826
Non-controlling interests and other (assets − liabilities − equity)—243−453———————
Net debt (negative = net cash)−48−35−394−664−587−220−359−344−474−503
Shares outstanding—44m—108m113m115m119m122m128m—

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: AZTA vs TXGTXG vs VCYTNEO vs TXGRGEN vs TXG

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to 10x Genomics, Inc.